John B. Thomas has been named executive vice president, strategy and investor relations at Horizon Pharma, reporting to Timothy P. Walbert, chairman, president and chief executive officer. He also joins the executive committee. Previously, Mr. Thomas served as vice president of investor relations and public affairs at Abbott, where he counseled the senior executive team on the financial community’s expectations regarding major acquisitions, divestitures, strategic partnerships, R&D an...